Granza Bio
Granza Bio is advancing therapeutic delivery with precision shells inspired by the body's immune system. They utilize the discovery of attack particles, autonomous entities from immune cells, to transform the fight against diseases such as cancers, autoimmunity, and infections. Their platform involves synthetically recreating attack particles to operate independently of immune cells, enabling targeted and effective delivery of therapeutic cargo to specific tissues and hard-to-reach organs.
Industries
Nr. of Employees
small (1-50)
Products
Precision shell delivery platform
A synthetic, biomimetic delivery platform designed to encapsulate and deliver diverse therapeutic cargos (including nucleic acids, proteins, genetic modifiers, and autonomous cytotoxic entities) while minimizing immune activation and enabling delivery to hard-to-reach tissues.
Precision shell delivery platform
A synthetic, biomimetic delivery platform designed to encapsulate and deliver diverse therapeutic cargos (including nucleic acids, proteins, genetic modifiers, and autonomous cytotoxic entities) while minimizing immune activation and enabling delivery to hard-to-reach tissues.
Services
Partnership-based development of delivery solutions using the precision shell platform, including payload formulation and targeting strategy development.
Partnership-based development of delivery solutions using the precision shell platform, including payload formulation and targeting strategy development.
Expertise Areas
- Therapeutic delivery platform development
- Biomimetic engineering of delivery vehicles
- RNA and protein therapeutic delivery
- Tissue-targeted delivery
Key Technologies
- Synthetic biomimetic shell/nanoparticle platforms
- RNA delivery
- Protein delivery
- Genetic modifier delivery